The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.75
Bid: 19.50
Ask: 20.00
Change: 0.25 (1.28%)
Spread: 0.50 (2.564%)
Open: 19.50
High: 19.75
Low: 19.50
Prev. Close: 19.50
IOF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IO#8 Brine Supply Update

4 May 2020 07:00

RNS Number : 7403L
Iofina PLC
04 May 2020
 

 

4 May 2020

 

Iofina Plc

("Iofina", the 'Group" or the "Company")

(LSE AIM: IOF)

 

IO#8 Brine Supply Update

 

 

Iofina plc, specialists in the exploration and production of iodine and manufacturers of specialty chemical products, today updates the market on brine supply to plant IO#8. 

 

IO#8 is Iofina's newest iodine plant located in western Oklahoma. Iofina's brine supply partner for IO#8 is a saltwater disposal (SWD) operator who sources brine from multiple hydrocarbon producers. On 1 May 2020, the SWD operator informed Iofina that oil and gas operators have shut-in or intend to shut-in wells due to reduced operating margins at current oil prices. Iofina believes this will materially affect the volumes of brine available for iodine isolation at IO#8.

 

Currently, IO#8 is operating and receiving brine, however, the Company expects the brine supply feeding IO#8 to significantly decline in the coming days. It is not clear if this is a short-term challenge or long-term supply issue and will depend on oil prices, oil demand, oil storage capacity, and the rate of USA economic recovery from COVID-19. Options to provide IO#8 with other brine sources are being investigated but it is unclear if a viable solution will be found. It is now unlikely that the Company will meet its H1 iodine production goals and Iofina will update the market when more information is apparent.

 

Iofina has four other iodine production plants located in its core area in NW Oklahoma. Brine supplies to these four plants have not been affected. These plants source brine from the Mississippi Lime oil field. The wells feeding these four plants are less susceptible to shut-ins due to higher volumes of oil produced per well and operators have hedged a significant portion of this established production.

 

COVID-19 has caused Iofina to continue to implement measures to safeguard employees, control costs and protect the Company's sourcing and sales channels. As previously announced, India sales and sourcing had slowed, however, the Company now reports that these challenges relating to the Indian market have reduced and are returning to normal. Iofina has not observed any significant changes in demand or pricing of iodine. Our workforce has had no positive COVID-19 cases. We are continuing to act dynamically to protect the business and its employees which includes applying for a loan through the US Small Business Administration's Paycheck Protection Program which will be announced if funds are received.

 

Commenting, President and CEO of Iofina Dr. Tom Becker, stated: "While the news of a likely significant reduction of brine supply to IO#8 resulting from oil well shut-ins during this time of extreme low oil prices and demand in the USA, is disappointing, we are otherwise pleased with the performance of the rest of the business during the COVID-19 pandemic. Iofina's other four iodine plants are fully operating and the Company expects this to continue. We are diligently working on possible solutions for IO#8 and will update the market as appropriate."

 

 

Enquiries:

 

Dr. Tom Becker

CEO & President

Iofina plc

Tel: +44 (0)20 3006 3135

 

Christopher Raggett/Giles Rolls/Matthew Radley (corporate finance)

Camille Gochez (ECM)

finnCap Ltd

Tel: +44 (0)20 7220 0500

 

Media Contact:

Charles Goodwin/Joe Burgess

Yellow Jersey PR Limited

Tel: +44 (0)20 3004 9512

About Iofina:

Iofina plc (AIM: IOF) is a vertically integrated Company that specialises in the production of Iodine and the manufacturing of specialty chemical products. As the second largest producer of iodine in North America, it comprises three USA entities; Iofina Resources, Iofina Chemical and IofinaEX.

 

LEI: 213800QDMFYVRJYYTQ84

ISIN: GB00B2QL5C79

 

Iofina Resources

Iofina Resources develops, builds, owns and operates iodine extraction plants using Iofina's WET® IOsorb® technology. Iofina currently operates five producing IOsorb® plants in Oklahoma and is consistently using technology and innovation to improve and expand its operations. 

 

Iofina Chemical

Iofina Chemical has manufactured high quality halogen speciality chemicals derived from raw iodine, as well as non-iodine based products for over 35 years.

 

IofinaEX

Iofina's newest subsidiary, IofinaEX, is fully licensed to process hemp in the state of Kentucky and is exploring the isolation of specialty chemical products from hemp, a rapidly expanding market.

 

www.iofina.com

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDFLFSAEFIVIII
Date   Source Headline
29th Aug 20194:35 pmRNSPrice Monitoring Extension
13th Aug 20197:00 amRNSIncorporation of IofinaEX Global
29th Jul 20197:00 amRNSGrant of Share Options
24th Jul 20193:08 pmRNSHolding(s) in Company
16th Jul 20192:17 pmRNSHolding(s) in Company
12th Jul 20197:00 amRNSH1 2019 Update
17th Jun 20191:49 pmRNSHolding(s) in Company
17th Jun 201910:55 amRNSHolding(s) in Company
17th Jun 201910:53 amRNSHolding(s) in Company
13th Jun 201912:00 pmRNSResult of AGM and Open Offer
13th Jun 20197:00 amRNSIofinaEX Application Conditionally Approved
20th May 20197:00 amRNSProposed Placing and Open Offer
14th May 20197:00 amRNSStatement regarding share price rise
1st May 20197:00 amRNSFinal Results
17th Apr 20197:00 amRNSQ1 2019 Market Update
1st Apr 20197:00 amRNSCompletion of Debt Restructuring
22nd Feb 20194:40 pmRNSSecond Price Monitoring Extn
22nd Feb 20194:35 pmRNSPrice Monitoring Extension
12th Feb 20197:00 amRNSDebt Restructuring
1st Feb 20194:40 pmRNSSecond Price Monitoring Extn
1st Feb 20194:35 pmRNSPrice Monitoring Extension
22nd Jan 20197:00 amRNSChange of Registered Office
17th Jan 20197:00 amRNSMarket Update
20th Nov 20184:40 pmRNSSecond Price Monitoring Extn
20th Nov 20184:35 pmRNSPrice Monitoring Extension
16th Nov 20187:00 amRNSDirector Appointment
18th Oct 20184:40 pmRNSSecond Price Monitoring Extn
18th Oct 20184:35 pmRNSPrice Monitoring Extension
10th Oct 20187:00 amRNSQ3 2018 Update
20th Sep 20187:00 amRNSInterim Results
16th Jul 20187:00 amRNSH1 2018 Update
18th Jun 20187:00 amRNSMarket update
14th Jun 20187:00 amRNSGrant of Options
13th Jun 201811:30 amRNSResult of AGM
30th Apr 20187:00 amRNSFinal Results and Notice of AGM
18th Apr 20187:00 amRNSQ1 2018 Market Update
16th Apr 20181:30 pmRNSHolding(s) in Company
11th Apr 20186:20 pmRNSHolding(s) in Company
11th Apr 20186:20 pmRNSHolding(s) in Company
20th Mar 20183:05 pmRNSHolding(s) in Company
15th Mar 20181:24 pmRNSHolding(s) in Company
14th Feb 20187:00 amRNSProduction commences at IO#7
30th Jan 20183:00 pmRNSHolding(s) in Company
15th Jan 20187:00 amRNSMarket Update
14th Dec 20177:00 amRNSMarket Update
16th Nov 20177:00 amRNSIO#7 Progress and Market Update
20th Oct 20174:40 pmRNSSecond Price Monitoring Extn
20th Oct 20174:35 pmRNSPrice Monitoring Extension
10th Oct 20177:00 amRNSQ3 2017 Market Update
22nd Sep 20177:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.